A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice
Open Access
- 19 August 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 17 (10) , 1293-1302
- https://doi.org/10.1093/intimm/dxh305
Abstract
DNA vaccination represents a novel therapeutic strategy for chronic hepatitis B virus (HBV) infection. Recently, some HBV DNA vaccines have been used in the preliminary clinical trials and exhibited exciting results in chronic HBV carriers. But these vaccines only encoded the single viral antigen, the S or the PreS2/S antigen. In this study, we designed a polytope DNA vaccine encoding multiple T cell epitopes. We found that it induced stronger CTL responses than the vaccine encoding the single antigen in H-2d and H-2b mice, although the CTL response to Ld-restricted epitope suppressed the CTLs to other epitopes in H-2d-restricted mice. Interestingly, heat shock protein 70 as an adjuvant not only enhanced CTL response to the viral antigen but also overcame this epitope suppression. Furthermore, the polytope DNA vaccine resulted in a long-term down-regulation of hepatitis B virus surface antigen and inhibition of HBV DNA replication in a HBV transgenic mouse model. Therefore, our research indicates that it is practicable and feasible to design a polytope DNA vaccine for chronic hepatitis B immunotherapy.Keywords
This publication has 35 references indexed in Scilit:
- Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriersHepatology, 2004
- Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigensVaccine, 2004
- The Lack of Effect of Therapeutic Vaccination With a Pre-S2/S HBV Vaccine in the Immune Tolerant Phase of Chronic HBV InfectionJournal of Clinical Gastroenterology, 2003
- Magnitude and Diversity of Cytotoxic-T-Lymphocyte Responses Elicited by Multiepitope DNA Vaccination in Rhesus MonkeysJournal of Virology, 2003
- CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccinationGene Therapy, 2003
- Endotoxin Contamination in Recombinant Human Heat Shock Protein 70 (Hsp70) Preparation Is Responsible for the Induction of Tumor Necrosis Factor α Release by Murine MacrophagesJournal of Biological Chemistry, 2003
- Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cellsEuropean Journal of Immunology, 2002
- Induction of Cell-Mediated Immunity againstMycobacterium tuberculosisUsing DNA Vaccines Encoding Cytotoxic and Helper T-Cell Epitopes of the 38-Kilodalton ProteinInfection and Immunity, 2001
- Heat shock proteins: the ‘Swiss Army Knife’ vaccines against cancers and infectious agentsVaccine, 2001
- Specific Vaccine Therapy in Chronic Hepatitis B: Induction of T Cell Proliferative Responses Specific for Envelope AntigensThe Journal of Infectious Diseases, 1999